| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |